- Home
- Appointees
- Michael Passante
Michael Passante
DAEO · 2021
Michael Passante, DAEO at the Office of National Drug Control Policy. 1 financial disclosure and ethics filing with the Office of Government Ethics, most recently Jan 15, 2021.
- Agency
- Office of National Drug Control Policy
- Ethics filings
- 1
- Latest filing
- Jan 15, 2021
Positions
- DAEO Office of National Drug Control Policy
Financial disclosure and ethics filings
- TerminationJan 15, 2021
Filed with the U.S. Office of Government Ethics. Form 278 reports list assets, income and debts; ethics agreements list what the official promised to sell or step away from.
Others who held this post at the Office of National Drug Control Policy
- Anthony D Jones 2021–2025
More officials at the Office of National Drug Control Policy
- Anne Sokolov Certificate of Divestiture
- Rahul Gupta Director
More
From Senate roll call votes, Wikidata, Wikipedia and Office of Government Ethics records.
Cite or embed this page
Capitol Receipts, “Michael Passante: DAEO, Office of National Drug Control Policy,” https://www.capitolreceipts.com/appointee/opassantemichael/michael-passante (accessed 2026-10-13).